The Oculofacial Podcast

Highlights from the Spring ASOPRS Scientific Symposium

We are joined by Dr. Peter Timoney, director of the spring meeting to recap all the highlights and get some behind the scenes insight. Dr. Lilly Wagner recaps the Orbit and Oncology sessions with her favorite take-aways and Dr. Katie Winkler shares the best of the Aesthetics and Practice Management sessions.

Perspectives on ACGME Accreditation and Fellowship Training

In this episode, ASOPRS Immediate Past President, Dr. Wendy Lee, moderates a candid roundtable with Drs. Don Kikkawa, John Holds, Evan Black, and Reza Vagefi, as they discuss ACGME accreditation of fellowship training. The panel weighs external validation, standardized training, and the potential for a new ABO subspecialty certification in the setting of ACGME requirements and some program director concerns about those requirements. Both ACGME accreditation of fellowships and participation in ABO Continuing Certification are two key components of an ABMS-compliant certification. Whether you're a member or simply invested in the future of oculofacial plastic surgery, this conversation is essential listening.

The Oculoplastics Specialty Over Time

Moderator: Dr. Deepak Ramesh [https://www.instagram.com/drdeepakramesh/] Guests: Dr. Rod Rohrich [https://www.instagram.com/rod.rohrich/] and Dr. John Holds [https://www.instagram.com/drjohnholds/] In the dynamic world of oculofacial plastic surgery, trends come and go, but some principles remain timeless. This post explores the evolution of eyelid surgery, the shift towards natural aesthetics, and the future of oculoplastics based on insights from leading experts in the field.

Surgical Spotlight on Myogenic Ptosis: Is it really any different?

Moderator: Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison) Guests · Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester · Dr. François Codère Associate Professor from the Université de Montréal in Canada · Dr. Richard Allen, Professor at Baylor in Texas In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected? Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.

Festoons & Malar Mounds: Mastering the Unmasterable

In this episode of The Oculofacial Podcast, host Dr. David Samimi is joined by an expert panel including Drs. Larry Kass, Allen Wulc, Julian Perry, and Adam Scheiner to discuss the management of one of the more challenging problems in aesthetic and reconstructive oculoplastic surgery – lower eyelid festoons and malar mounds. The conversation covers topics including patient evaluation, treatment selection, laser resurfacing, injectable tetracycline, surgical techniques, midface lifting, fat grafting, direct festoon excision, and pearls for avoiding complications and recurrence. They also discuss why patient counseling and expectation management are critical to achieving successful outcomes. Each expert offers their own personal experience in the treatment of festoons to deliver expert insights and treatment and surgical pearls. Disclaimer: The opinions and perspectives expressed by participants are their own and are shared for informational discussion purposes only. Statements made during the podcast may not be those of ASOPRS or the ASOPRS Board of Directors.